Cannabidiol for Obsessive-Compulsive Disorder

"According to clinicaltrials.gov, this trail is actively enlisting volunteers and has been running since April 14th 2022 (with updates up until June 28th)."

"This study's inclusion criteria mandates that potential participants should be between 18 and 65 years of age. For those younger than 18, there are 287 trials available; for seniors over the age of 65, 733 studies exist."

"The safety rating of Cannabidiol was estimated to be 2 on our scale, as this is a Phase 2 trial which has yielded data attesting to its risk profile but not its efficacy."

"Indeed, the information available on clinicaltrials.gov demonstrates that this research trial is currently in its recruitment phase. It began being advertised online on April 14th 2022 and has been recently updated as of June 28th 2022. This study requires 15 participants from a single site to be enrolled."

"Currently, 79 trials are underway that focus on Cannabidiol. Of those studies, 16 have moved into Phase 3 of their research process. Despite the majority being based in Ribeirao Preto (Sao Paulo), there are a total of 290 sites working with this drug."

"The primary goal of this 8-week trial is to evaluate the efficacy of a treatment via changes in NIMH Symptom Severity Scale scores. Secondary objectives include gaugeing patient progress with Clinical Global Impressions- Improvement Scale, Hamilton Depression Rating Scale and Sheehan Disability Scale assessments at each visit."

"This study is attempting to recruit 15 individuals aged 18-65 that present with Hoarding Disorder. In order to qualify for this trial, the patient must meet certain standards such as being of legal age and exhibiting a Young Brown Obsessive Compulsive Scale score of at least 18 upon initial assessment. Additionally, they must comprehend and agree to the terms outlined in the informed consent document."